{"id":816249,"date":"2025-02-21T09:07:10","date_gmt":"2025-02-21T14:07:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/"},"modified":"2025-02-21T09:07:10","modified_gmt":"2025-02-21T14:07:10","slug":"hims-hers-acquires-us-based-peptide-facility","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/","title":{"rendered":"Hims &amp; Hers Acquires US-based Peptide Facility"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Hims &amp; Hers Acquires US-based Peptide Facility<\/b><\/p>\n<p class=\"bwalignc\"><i>The acquisition will strengthen the long-term durability of the company\u2019s domestic supply chain, helping to ensure Americans can consistently access personalized medications<\/i><\/p>\n<p>SAN FRANCISCO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nHims &amp; Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company\u2019s long-term ability to deliver personalized medications. The company has acquired a US-based peptide facility based in California. The acquisition will enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment options.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250221057156\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250221057156\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/4\/2025_Newsroom_Peptides_Businesswire.jpg\" alt=\"The acquisition will strengthen the long-term durability of the company\u2019s domestic supply chain, helping to ensure Americans can consistently access personalized medications. (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">The acquisition will strengthen the long-term durability of the company\u2019s domestic supply chain, helping to ensure Americans can consistently access personalized medications. (Photo: Business Wire)<\/p>\n<\/div>\n<p>\n\u201cThe future of healthcare must be centered on the customer, which is why our operational structure is built to scale personalized care to more individuals at the highest standard of quality and safety, and with a focus on long-term consistency and availability,\u201d said Melissa Baird, COO of Hims &amp; Hers. \u201cWe&#8217;re building our supply chain to enable more Americans to access care, including personalized treatments designed around their needs. This acquisition is a reflection of our commitment to those goals and our ongoing investment in the customer from start to finish.\u201d\n<\/p>\n<p>\nFollowing the company\u2019s past acquisitions of 503A and 503B facilities, this additional facility deepens the company\u2019s commitment to maintaining operations in the United States for better insight into cost, availability and quality, more fully verticalizing the efficiency and durability of the supply chain, and furthering the company\u2019s focus on quality and safety for every customer on the platform. In addition, the peptide capabilities made possible through this acquisition position the company in the coming years to explore exciting advances in peptide innovation, including across areas of consumer need such as preventive health, metabolic optimization, cognitive performance, recovery science, and biological resistances.\n<\/p>\n<p>\nThe acquisition closed in early February, and Hims &amp; Hers expects to continue strengthening infrastructure capabilities as demand for personalized treatment continues to grow.\n<\/p>\n<p>\nFor more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hims.com%2Famerican-made&amp;esheet=54211374&amp;newsitemid=20250221057156&amp;lan=en-US&amp;anchor=www.hims.com%2Famerican-made&amp;index=1&amp;md5=6202b53f88605dff2692a4543bbcaffc\">www.hims.com\/american-made<\/a>.\n<\/p>\n<p><b>About Hims &amp; Hers Health, Inc<\/b><\/p>\n<p>\nHims &amp; Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That\u2019s why we\u2019re building a future where nothing stands in the way of harnessing this power. Hims &amp; Hers normalizes health &amp; wellness challenges\u2014and innovates on their solutions\u2014to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hims.com&amp;esheet=54211374&amp;newsitemid=20250221057156&amp;lan=en-US&amp;anchor=www.hims.com&amp;index=2&amp;md5=ba768d3e0d1bda3e9b2b4ab7dd6ab56f\">www.hims.com<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.forhers.com&amp;esheet=54211374&amp;newsitemid=20250221057156&amp;lan=en-US&amp;anchor=www.forhers.com&amp;index=3&amp;md5=e02e03b27fafc42e11319a91fca16cfd\">www.forhers.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250221057156r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250221057156\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250221057156\/en\/<\/a><\/span><\/p>\n<p>\nPress Contact<br \/>\n<br \/>Abby Reisinger<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:press@forhims.com\">press@forhims.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Manufacturing Vitamins\/Supplements Fitness &amp; Nutrition Manufacturing Biotechnology Health Pharmaceutical Retail Supply Chain Management<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/3\/2025_Newsroom_Peptides_Businesswire.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">The acquisition will strengthen the long-term durability of the company\u2019s domestic supply chain, helping to ensure Americans can consistently access personalized medications. (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388732\/3\/Hims_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Hims &amp; Hers Acquires US-based Peptide Facility The acquisition will strengthen the long-term durability of the company\u2019s domestic supply chain, helping to ensure Americans can consistently access personalized medications SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; Hims &amp; Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company\u2019s long-term ability to deliver personalized medications. The company has acquired a US-based peptide facility based in California. The acquisition will enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment options. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250221057156\/en\/ The acquisition will strengthen the long-term durability of the company\u2019s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Hims &amp; Hers Acquires US-based Peptide Facility&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816249","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hims &amp; Hers Acquires US-based Peptide Facility - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hims &amp; Hers Acquires US-based Peptide Facility - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Hims &amp; Hers Acquires US-based Peptide Facility The acquisition will strengthen the long-term durability of the company\u2019s domestic supply chain, helping to ensure Americans can consistently access personalized medications SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; Hims &amp; Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company\u2019s long-term ability to deliver personalized medications. The company has acquired a US-based peptide facility based in California. The acquisition will enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment options. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250221057156\/en\/ The acquisition will strengthen the long-term durability of the company\u2019s &hellip; Continue reading &quot;Hims &amp; Hers Acquires US-based Peptide Facility&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-21T14:07:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/4\/2025_Newsroom_Peptides_Businesswire.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Hims &amp; Hers Acquires US-based Peptide Facility\",\"datePublished\":\"2025-02-21T14:07:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/\"},\"wordCount\":569,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250221057156\\\/en\\\/2388735\\\/4\\\/2025_Newsroom_Peptides_Businesswire.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/\",\"name\":\"Hims &amp; Hers Acquires US-based Peptide Facility - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250221057156\\\/en\\\/2388735\\\/4\\\/2025_Newsroom_Peptides_Businesswire.jpg\",\"datePublished\":\"2025-02-21T14:07:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250221057156\\\/en\\\/2388735\\\/4\\\/2025_Newsroom_Peptides_Businesswire.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250221057156\\\/en\\\/2388735\\\/4\\\/2025_Newsroom_Peptides_Businesswire.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-acquires-us-based-peptide-facility\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hims &amp; Hers Acquires US-based Peptide Facility\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hims &amp; Hers Acquires US-based Peptide Facility - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/","og_locale":"en_US","og_type":"article","og_title":"Hims &amp; Hers Acquires US-based Peptide Facility - Market Newsdesk","og_description":"Hims &amp; Hers Acquires US-based Peptide Facility The acquisition will strengthen the long-term durability of the company\u2019s domestic supply chain, helping to ensure Americans can consistently access personalized medications SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; Hims &amp; Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company\u2019s long-term ability to deliver personalized medications. The company has acquired a US-based peptide facility based in California. The acquisition will enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment options. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20250221057156\/en\/ The acquisition will strengthen the long-term durability of the company\u2019s &hellip; Continue reading \"Hims &amp; Hers Acquires US-based Peptide Facility\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-21T14:07:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/4\/2025_Newsroom_Peptides_Businesswire.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Hims &amp; Hers Acquires US-based Peptide Facility","datePublished":"2025-02-21T14:07:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/"},"wordCount":569,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/4\/2025_Newsroom_Peptides_Businesswire.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/","name":"Hims &amp; Hers Acquires US-based Peptide Facility - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/4\/2025_Newsroom_Peptides_Businesswire.jpg","datePublished":"2025-02-21T14:07:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/4\/2025_Newsroom_Peptides_Businesswire.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250221057156\/en\/2388735\/4\/2025_Newsroom_Peptides_Businesswire.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-acquires-us-based-peptide-facility\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Hims &amp; Hers Acquires US-based Peptide Facility"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816249"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816249\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}